March 2025 Stock Losers on News, Micro Caps Included

Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.

Data as of the trading session of 2025-03-31, 20 of 21 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

See the biggest gainers of March 2025

100

Ranked drops

-77.14%

Largest, ACON

96.9%

Below baseline, day +5

11.1%

Median deeper below baseline, day +5

Filter and sort

100 ranked drops in March 2025

Skip the ranked rows and go to the month summary

Every percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.

Rank	Symbol	close to close	Session	Catalyst	Announcement	from the pre-news close
1	ACON under $25M today Also on the opposite board this month on both boards	-77.14%	2025-03-06 against the close of 2025-03-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey 03/06/2025 09:35 ET intraday	Day +1 -80.29% 2025-03-07 Day +5 -90.21% 2025-03-13 Best recovery within 5 -80.29% 2025-03-07 Five sessions later the drop was 16.9% bigger, at -90.21%. Month end -94.29% on 2025-03-31
Close before and after $189.00 to $43.20 split-adjusted Session open, high, low $57.24, $61.02, $28.35 Opening gap -69.71% Close inside the session range 0.45 of the range, where 1.00 is the high Session volume 1,908,358 shares, $82,441,066 Relative volume 123.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
2	NOVA	-64.25%	2025-03-03 against the close of 2025-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Sunnova Reports Fourth Quarter and Full Year 2024 Financial Results 03/03/2025 06:09 ET premarket	Day +1 -59.35% 2025-03-04 Day +5 -69.33% 2025-03-10 Best recovery within 5 -59.35% 2025-03-04 Five sessions later the drop was 7.9% bigger, at -69.33%. Month end -77.59% on 2025-03-31
Close before and after $1.66 to $0.5935 as traded Session open, high, low $0.6161, $0.8500, $0.4800 Opening gap -62.89% Close inside the session range 0.31 of the range, where 1.00 is the high Session volume 118,371,352 shares, $70,253,397 Relative volume 13.5x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
3	CUTR under $25M today Also on the opposite board this month on both boards	-63.26%	2025-03-05 against the close of 2025-03-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Cutera Takes Steps to Strengthen Financial Foundation and Position the Company for Long-Term Success 03/05/2025 07:10 ET premarket	Day +1 -62.85% 2025-03-06 Day +5 -69.18% 2025-03-12 Best recovery within 5 -59.13% 2025-03-10 Five sessions later the drop was 9.4% bigger, at -69.18%. Month-end is not shown: no closing price is available for 2025-03-31.
Close before and after $0.3144 to $0.1155 as traded Session open, high, low $0.1567, $0.1797, $0.1155 Opening gap -50.16% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 23,222,455 shares, $2,682,194 Relative volume 141.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
4	NVNI under $25M today release reads positive	-63.00%	2025-03-03 against the close of 2025-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement Release reads positive, stock fell 63.00%	Nvni Group Engages MZ Group to Lead Investor Relations and Shareholder Communications Program 03/03/2025 08:30 ET premarket	Day +1 -74.01% 2025-03-04 Day +5 -72.53% 2025-03-10 Best recovery within 5 -72.53% 2025-03-10 Five sessions later the drop was 15.1% bigger, at -72.53%. Month end -78.79% on 2025-03-31
Close before and after $10.10 to $3.74 split-adjusted Session open, high, low $5.79, $6.04, $3.54 Opening gap -42.67% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 3,831,103 shares, $14,316,832 Relative volume 66.0x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
5	DTC	-62.87%	2025-03-12 against the close of 2025-03-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Solo Brands, Inc. Announces Fourth Quarter and Fiscal Year 2024 Results 03/12/2025 07:00 ET premarket Solo Brands Announces Appointment of Peter Laurinaitis to its Board of Directors 03/12/2025	Day +1 -66.41% 2025-03-13 Day +5 -64.63% 2025-03-19 Best recovery within 5 -64.05% 2025-03-14 Five sessions later the drop was 2.8% bigger, at -64.63%. Month end -74.38% on 2025-03-31
Close before and after $0.6550 to $0.2432 as traded Session open, high, low $0.4688, $0.4688, $0.2340 Opening gap -28.43% Close inside the session range 0.04 of the range, where 1.00 is the high Session volume 6,943,848 shares, $1,688,744 Relative volume 29.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
6	MURA	-61.62%	2025-03-25 against the close of 2025-03-24 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Mural Oncology Provides Update on Phase 3 ARTISTRY-7 Trial of Nemvaleukin in Combination with KEYTRUDA® (pembrolizumab) in Patients with Platinum-Resistant Ovarian Cancer 03/25/2025 06:30 ET premarket	Day +1 -65.27% 2025-03-26 Day +5 -67.62% 2025-04-01 Best recovery within 5 -64.75% 2025-03-27 Five sessions later the drop was 9.7% bigger, at -67.62%. Month end -67.10% on 2025-03-31 This month ended before the fifth session after the move.
Close before and after $3.83 to $1.47 as traded Session open, high, low $1.78, $1.82, $1.37 Opening gap -53.52% Close inside the session range 0.22 of the range, where 1.00 is the high Session volume 4,043,135 shares, $5,943,408 Relative volume 38.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
7	MIST	-60.89%	2025-03-28 against the close of 2025-03-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	FDA Issues Complete Response Letter for Etripamil for PSVT 03/28/2025 07:00 ET premarket	Day +1 -64.44% 2025-03-31 Day +5 -69.08% 2025-04-04 Best recovery within 5 -64.31% 2025-04-02 Five sessions later the drop was 13.5% bigger, at -69.08%. Month end -64.44% on 2025-03-31 This month ended before the fifth session after the move.
Close before and after $2.25 to $0.8800 split-adjusted Session open, high, low $0.7648, $1.32, $0.7500 Opening gap -66.01% Close inside the session range 0.23 of the range, where 1.00 is the high Session volume 33,525,778 shares, $29,502,685 Relative volume 14.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
8	PLRX	-59.88%	2025-03-03 against the close of 2025-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis 03/03/2025 09:27 ET premarket	Day +1 -60.76% 2025-03-04 Day +5 -58.43% 2025-03-10 Best recovery within 5 -52.91% 2025-03-07 2.4% of the drop was recovered five sessions later. Month end -60.76% on 2025-03-31
Close before and after $3.44 to $1.38 split-adjusted Session open, high, low $3.10, $3.25, $1.37 Opening gap -9.88% Close inside the session range 0.01 of the range, where 1.00 is the high Session volume 19,506,632 shares, $26,919,152 Relative volume 8.2x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
9	TDTH	-59.65%	2025-03-27 against the close of 2025-03-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Buyback / Dividend	Trident Announces $1,000,000 Share Repurchase Program 03/27/2025 04:00 ET premarket	Day +1 -73.18% 2025-03-28 Day +5 -85.47% 2025-04-03 Best recovery within 5 -73.18% 2025-03-28 Five sessions later the drop was 43.3% bigger, at -85.47%. Month end -77.09% on 2025-03-31 This month ended before the fifth session after the move.
Close before and after $45.30 to $18.28 split-adjusted Session open, high, low $56.10, $58.50, $15.36 Opening gap +23.83% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 1,508,351 shares, $27,575,673 Relative volume 413.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
10	AGMH under $25M today	-59.53%	2025-03-03 against the close of 2025-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	AGM Group Holdings Inc. Announces Pricing of $5.4 Million Public Offering 03/02/2025 22:15 ET after hours	Day +1 -68.05% 2025-03-04 Day +5 -60.44% 2025-03-10 Best recovery within 5 -34.57% 2025-03-06 Five sessions later the drop was 1.5% bigger, at -60.44%. Month end -85.82% on 2025-03-31
Close before and after $16.43 to $6.65 split-adjusted Session open, high, low $7.35, $8.30, $6.25 Opening gap -55.26% Close inside the session range 0.20 of the range, where 1.00 is the high Session volume 189,495 shares, $1,260,142 Relative volume 235.8x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
11	ME Also on the opposite board this month on both boards	-59.22%	2025-03-24 against the close of 2025-03-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	23andMe Initiates Voluntary Chapter 11 Process to Maximize Stakeholder Value Through Court-Supervised Sale Process 03/23/2025 23:08 ET after hours	Day +1 -63.69% 2025-03-25 Day +5 no data Best recovery within 5 so far -56.98% 2025-03-27 Month-end is not shown: no closing price is available for 2025-03-31.
Close before and after $1.79 to $0.7300 as traded Session open, high, low $0.9187, $0.9700, $0.7300 Opening gap -48.68% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 6,971,023 shares, $5,088,847 Relative volume 29.8x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
12	LXRX Also on the opposite board this month on both boards	-58.17%	2025-03-03 against the close of 2025-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Lexicon Pharmaceuticals to Announce Topline Results from Phase 2b PROGRESS Study Evaluating Pilavapadin (LX9211) in Adults with Diabetic Peripheral Neuropathic Pain 03/02/2025 16:13 ET after hours Lexicon Pharmaceuticals Announces Topline Results from Phase 2b PROGRESS Study Evaluating Pilavapadin (LX9211) in Adults with Diabetic Peripheral Neuropathic Pain 03/03/2025	Day +1 -53.57% 2025-03-04 Day +5 -49.29% 2025-03-10 Best recovery within 5 -43.99% 2025-03-07 15.3% of the drop was recovered five sessions later. Month end -34.12% on 2025-03-31
Close before and after $0.6995 to $0.2926 split-adjusted Session open, high, low $0.3746, $0.4498, $0.2836 Opening gap -46.45% Close inside the session range 0.05 of the range, where 1.00 is the high Session volume 61,639,150 shares, $18,035,615 Relative volume 20.6x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
13	BON under $25M today More than one ranked move this month 2+ ranked moves	-57.46%	2025-03-17 against the close of 2025-03-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Bon Natural Life Limited Announces Pricing of $12 Million Best Efforts Offering 03/17/2025 09:00 ET premarket	Day +1 -67.62% 2025-03-18 Day +5 -89.65% 2025-03-24 Best recovery within 5 -67.62% 2025-03-18 Five sessions later the drop was 56.0% bigger, at -89.65%. Month end -93.51% on 2025-03-31
Close before and after $36.00 to $15.32 split-adjusted Session open, high, low $20.50, $21.74, $13.83 Opening gap -43.06% Close inside the session range 0.19 of the range, where 1.00 is the high Session volume 918,310 shares, $14,063,918 Relative volume 394.5x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
14	PSTV More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards	-54.21%	2025-03-04 against the close of 2025-03-03 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Plus Therapeutics Secures Private Placement of Approximately $15 Million in Gross Proceeds 03/04/2025 14:06 ET intraday	Day +1 -46.97% 2025-03-05 Day +5 +116.67% 2025-03-11 Best recovery within 5 +137.88% 2025-03-07 It recovered the whole drop and closed 116.67% above the pre-news price. Month end +43.95% on 2025-03-31
Close before and after $16.50 to $7.56 split-adjusted Session open, high, low $16.27, $17.24, $6.00 Opening gap -1.39% Close inside the session range 0.14 of the range, where 1.00 is the high Session volume 191,184 shares, $1,444,395 Relative volume 118.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
15	TNYA	-53.53%	2025-03-04 against the close of 2025-03-03 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Tenaya Therapeutics Announces Proposed Public Offering 03/03/2025 16:10 ET after hours Tenaya Therapeutics Announces Pricing of Public Offering 03/03/2025	Day +1 -51.95% 2025-03-05 Day +5 -42.97% 2025-03-11 Best recovery within 5 -42.97% 2025-03-11 19.7% of the drop was recovered five sessions later. Month end -39.79% on 2025-03-31
Close before and after $0.9469 to $0.4400 split-adjusted Session open, high, low $0.7000, $0.7000, $0.3941 Opening gap -26.07% Close inside the session range 0.15 of the range, where 1.00 is the high Session volume 26,280,208 shares, $11,563,292 Relative volume 19.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
16	ARVN release reads positive	-52.73%	2025-03-11 against the close of 2025-03-10 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results Release reads positive, stock fell 52.73%	Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical Trial 03/11/2025 06:45 ET premarket	Day +1 -48.58% 2025-03-12 Day +5 -52.05% 2025-03-18 Best recovery within 5 -48.58% 2025-03-12 1.3% of the drop was recovered five sessions later. Month end -60.02% on 2025-03-31
Close before and after $17.56 to $8.30 split-adjusted Session open, high, low $10.58, $10.78, $7.91 Opening gap -39.75% Close inside the session range 0.14 of the range, where 1.00 is the high Session volume 19,027,388 shares, $157,927,320 Relative volume 14.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
17	CNSP under $25M today	-51.78%	2025-03-25 against the close of 2025-03-24 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	CNS Pharmaceuticals Announces Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme 03/25/2025 08:00 ET premarket	Day +1 -58.28% 2025-03-26 Day +5 -61.83% 2025-04-01 Best recovery within 5 -58.28% 2025-03-26 Five sessions later the drop was 19.4% bigger, at -61.83%. Month end -59.76% on 2025-03-31 This month ended before the fifth session after the move.
Close before and after $40.56 to $19.56 split-adjusted Session open, high, low $18.12, $19.91, $15.36 Opening gap -55.33% Close inside the session range 0.92 of the range, where 1.00 is the high Session volume 200,079 shares, $3,913,545 Relative volume 11.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
18	XTIA	-50.00%	2025-03-28 against the close of 2025-03-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	XTI Aerospace Announces Proposed Public Offering 03/27/2025 18:57 ET after hours XTI Aerospace Announces Pricing of Public Offering 03/28/2025	Day +1 -55.69% 2025-03-31 Day +5 -55.28% 2025-04-04 Best recovery within 5 -53.66% 2025-04-02 Five sessions later the drop was 10.6% bigger, at -55.28%. Month end -55.69% on 2025-03-31 This month ended before the fifth session after the move.
Close before and after $2.46 to $1.23 split-adjusted Session open, high, low $1.32, $1.34, $1.20 Opening gap -46.34% Close inside the session range 0.21 of the range, where 1.00 is the high Session volume 1,820,968 shares, $2,239,791 Relative volume 8.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
19	EU	-46.43%	2025-03-03 against the close of 2025-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	enCore Energy Corp. Reports Fiscal Year 2024 Financial Results and Files Annual Report on Form 10-K 03/03/2025 07:00 ET premarket	Day +1 -32.94% 2025-03-04 Day +5 -42.66% 2025-03-10 Best recovery within 5 -29.76% 2025-03-05 8.1% of the drop was recovered five sessions later. Month end -45.63% on 2025-03-31
Close before and after $2.52 to $1.35 split-adjusted Session open, high, low $2.40, $2.46, $1.26 Opening gap -4.76% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 21,491,876 shares, $29,014,033 Relative volume 14.3x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
20	PCVX	-45.64%	2025-03-31 against the close of 2025-03-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study 03/31/2025 07:00 ET premarket Vaxcyte to Host Webcast and Conference Call to Present Topline Results from VAX-24 Infant Phase 2 Study 03/30/2025	Day +1 -53.60% 2025-04-01 Day +5 -53.20% 2025-04-07 Best recovery within 5 -51.50% 2025-04-02 Five sessions later the drop was 16.6% bigger, at -53.20%. Month end -45.64% on 2025-03-31 same session This month ended before the fifth session after the move.
Close before and after $69.46 to $37.76 split-adjusted Session open, high, low $33.07, $37.94, $30.12 Opening gap -52.39% Close inside the session range 0.98 of the range, where 1.00 is the high Session volume 14,001,616 shares, $528,701,020 Relative volume 13.1x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
21	SOWG	-44.00%	2025-03-21 against the close of 2025-03-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Sow Good Reports Fourth Quarter 2024 Results 03/21/2025 08:00 ET premarket	Day +1 -57.82% 2025-03-24 Day +5 -61.09% 2025-03-28 Best recovery within 5 -57.82% 2025-03-24 Five sessions later the drop was 38.8% bigger, at -61.09%. Month end -63.27% on 2025-03-31
Close before and after $41.25 to $23.10 split-adjusted Session open, high, low $28.65, $29.99, $21.75 Opening gap -30.55% Close inside the session range 0.16 of the range, where 1.00 is the high Session volume 46,535 shares, $1,074,959 Relative volume 30.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
22	ELEV under $25M today	-41.82%	2025-03-20 against the close of 2025-03-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement (terminated)	Elevation Oncology to Discontinue Development of EO-3021; Advancing EO-1022, While Evaluating Strategic Options 03/20/2025 08:00 ET premarket	Day +1 -37.19% 2025-03-21 Day +5 -45.56% 2025-03-27 Best recovery within 5 -37.19% 2025-03-21 Five sessions later the drop was 8.9% bigger, at -45.56%. Month end -45.77% on 2025-03-31
Close before and after $0.4778 to $0.2780 as traded Session open, high, low $0.2735, $0.3196, $0.2410 Opening gap -42.76% Close inside the session range 0.47 of the range, where 1.00 is the high Session volume 18,189,250 shares, $5,056,612 Relative volume 23.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
23	BHIL under $25M today More than one ranked move this month 2+ ranked moves	-41.19%	2025-03-26 against the close of 2025-03-25 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Benson Hill Receives Court Approval of First-Day Motions to Support Ongoing Operations During Chapter 11 Process 03/25/2025 16:45 ET after hours	Day +1 no data Day +5 no data Best recovery within 5 no data Month-end is not shown: no closing price is available for 2025-03-31.
Close before and after $0.4234 to $0.2490 as traded Session open, high, low $0.3800, $0.3900, $0.2215 Opening gap -10.25% Close inside the session range 0.16 of the range, where 1.00 is the high Session volume 2,119,386 shares, $527,727 Relative volume 36.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
24	MGRX under $25M today	-40.84%	2025-03-25 against the close of 2025-03-24 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada 03/25/2025 09:00 ET premarket	Day +1 -48.00% 2025-03-26 Day +5 -54.74% 2025-04-01 Best recovery within 5 -48.00% 2025-03-26 Five sessions later the drop was 34.0% bigger, at -54.74%. Month end -58.95% on 2025-03-31 This month ended before the fifth session after the move.
Close before and after $4.75 to $2.81 split-adjusted Session open, high, low $4.74, $4.99, $2.65 Opening gap -0.21% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 3,201,432 shares, $8,996,024 Relative volume 56.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
25	BHIL under $25M today More than one ranked move this month 2+ ranked moves	-40.50%	2025-03-20 against the close of 2025-03-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Benson Hill Files Voluntary Chapter 11 Petitions 03/20/2025 09:00 ET premarket	Day +1 -45.77% 2025-03-21 Day +5 no data Best recovery within 5 so far -34.40% 2025-03-25 Month-end is not shown: no closing price is available for 2025-03-31.
Close before and after $0.6454 to $0.3840 as traded Session open, high, low $0.3872, $0.4599, $0.3350 Opening gap -40.01% Close inside the session range 0.39 of the range, where 1.00 is the high Session volume 1,471,542 shares, $565,072 Relative volume 28.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
26	ULY under $25M today	-40.35%	2025-03-13 against the close of 2025-03-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Urgently Announces Fourth Quarter and Full-Year 2024 Financial Results 03/12/2025 16:05 ET after hours	Day +1 -42.88% 2025-03-14 Day +5 -21.02% 2025-03-20 Best recovery within 5 -21.02% 2025-03-20 47.9% of the drop was recovered five sessions later. Month end -23.63% on 2025-03-31
Close before and after $6.12 to $3.65 as traded Session open, high, low $4.83, $4.83, $3.02 Opening gap -21.08% Close inside the session range 0.35 of the range, where 1.00 is the high Session volume 146,517 shares, $534,494 Relative volume 13.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
27	XPOF	-38.45%	2025-03-14 against the close of 2025-03-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Xponential Fitness, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results 03/13/2025 16:05 ET after hours	Day +1 -24.17% 2025-03-17 Day +5 -28.55% 2025-03-21 Best recovery within 5 -24.17% 2025-03-17 25.7% of the drop was recovered five sessions later. Month end -31.27% on 2025-03-31
Close before and after $12.12 to $7.46 split-adjusted Session open, high, low $7.62, $8.36, $7.22 Opening gap -37.13% Close inside the session range 0.21 of the range, where 1.00 is the high Session volume 6,973,562 shares, $52,022,773 Relative volume 14.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
28	ADAP under $25M today	-37.65%	2025-03-20 against the close of 2025-03-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Adaptimmune Provides Q4 and Full Year 2024 Business Update 03/20/2025 07:00 ET premarket	Day +1 -35.25% 2025-03-21 Day +5 -51.01% 2025-03-27 Best recovery within 5 -35.25% 2025-03-21 Five sessions later the drop was 35.5% bigger, at -51.01%. Month end -56.13% on 2025-03-31
Close before and after $0.4491 to $0.2800 as traded Session open, high, low $0.4300, $0.4330, $0.2614 Opening gap -4.25% Close inside the session range 0.11 of the range, where 1.00 is the high Session volume 14,047,016 shares, $3,933,164 Relative volume 12.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
29	TELA	-37.18%	2025-03-21 against the close of 2025-03-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results 03/20/2025 16:05 ET after hours	Day +1 -40.17% 2025-03-24 Day +5 -47.22% 2025-03-28 Best recovery within 5 -40.17% 2025-03-24 Five sessions later the drop was 27.0% bigger, at -47.22%. Month end -47.86% on 2025-03-31
Close before and after $2.34 to $1.47 split-adjusted Session open, high, low $1.90, $1.90, $1.28 Opening gap -18.80% Close inside the session range 0.31 of the range, where 1.00 is the high Session volume 2,932,529 shares, $4,310,818 Relative volume 19.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
30	VG	-36.05%	2025-03-06 against the close of 2025-03-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Venture Global Reports Fourth Quarter and Full Year 2024 Results 03/06/2025 06:14 ET premarket Venture Global Announces Major Brownfield Expansion of Plaquemines LNG 03/06/2025	Day +1 -35.14% 2025-03-07 Day +5 -31.97% 2025-03-13 Best recovery within 5 -27.97% 2025-03-12 11.3% of the drop was recovered five sessions later. Month end -27.62% on 2025-03-31
Close before and after $14.23 to $9.10 split-adjusted Session open, high, low $11.38, $11.73, $8.72 Opening gap -20.06% Close inside the session range 0.13 of the range, where 1.00 is the high Session volume 44,596,081 shares, $405,824,337 Relative volume 8.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
31	SCNX under $25M today	-35.89%	2025-03-18 against the close of 2025-03-17 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	SCIENTURE announces the U.S. FDA Approval of its NDA for SCN-102, to be launched as ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL. The global market for losartan potassium was approximately $1.5 billion in sales in 2024. 03/18/2025 08:05 ET premarket	Day +1 -23.39% 2025-03-19 Day +5 -28.63% 2025-03-25 Best recovery within 5 -18.95% 2025-03-21 20.2% of the drop was recovered five sessions later. Month end -41.94% on 2025-03-31
Close before and after $2.48 to $1.59 split-adjusted Session open, high, low $3.03, $3.17, $1.53 Opening gap +22.18% Close inside the session range 0.04 of the range, where 1.00 is the high Session volume 62,793,468 shares, $99,841,614 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
32	IRBT under $25M today release reads positive	-35.66%	2025-03-12 against the close of 2025-03-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings catalyst from a later release the same session Release reads positive, stock fell 35.66%	iRobot Introduces Suite of Innovative ROOMBA® Floor Cleaning Robots 03/11/2025 16:01 ET after hours iRobot Reports Fourth-Quarter and Full-Year 2024 Financial Results 03/12/2025 iRobot Appoints Neal P. Goldman to Board of Directors 03/12/2025	Day +1 -51.58% 2025-03-13 Day +5 -45.96% 2025-03-19 Best recovery within 5 -40.25% 2025-03-17 Five sessions later the drop was 28.9% bigger, at -45.96%. Month end -57.21% on 2025-03-31
Close before and after $6.31 to $4.06 as traded Session open, high, low $4.01, $4.48, $3.63 Opening gap -36.45% Close inside the session range 0.51 of the range, where 1.00 is the high Session volume 17,314,195 shares, $70,295,632 Relative volume 9.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
33	EQ	-35.62%	2025-03-27 against the close of 2025-03-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Equillium Announces Results of the Phase 3 EQUATOR Study of Itolizumab in First-Line Treatment of Patients with Acute Graft-Versus-Host Disease 03/27/2025 07:00 ET premarket Equillium Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate and Clinical Highlights 03/27/2025	Day +1 -46.52% 2025-03-28 Day +5 -38.13% 2025-04-03 Best recovery within 5 -33.54% 2025-04-01 Five sessions later the drop was 7.0% bigger, at -38.13%. Month end -48.25% on 2025-03-31 This month ended before the fifth session after the move.
Close before and after $0.7580 to $0.4880 split-adjusted Session open, high, low $0.5000, $0.6020, $0.4101 Opening gap -34.04% Close inside the session range 0.41 of the range, where 1.00 is the high Session volume 1,340,429 shares, $654,129 Relative volume 30.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
34	STRO release reads positive	-35.19%	2025-03-14 against the close of 2025-03-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings catalyst from a later release the same session Release reads positive, stock fell 35.19%	Sutro Biopharma Announces Strategic Portfolio Review Resulting in the Prioritization of its Next-Generation ADC Pipeline 03/13/2025 16:05 ET after hours Sutro Biopharma Reports Full Year 2024 Financial Results and Business Highlights 03/13/2025	Day +1 -25.41% 2025-03-17 Day +5 -38.65% 2025-03-21 Best recovery within 5 -25.41% 2025-03-17 Five sessions later the drop was 9.8% bigger, at -38.65%. Month end -47.95% on 2025-03-31
Close before and after $12.50 to $8.10 split-adjusted Session open, high, low $9.99, $10.10, $8.08 Opening gap -20.08% Close inside the session range 0.01 of the range, where 1.00 is the high Session volume 1,512,600 shares, $12,253,573 Relative volume 17.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
35	SMSI under $25M today	-34.07%	2025-03-12 against the close of 2025-03-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Smith Micro Reports Fourth Quarter and Fiscal Year 2024 Financial Results 03/11/2025 16:05 ET after hours	Day +1 -32.09% 2025-03-13 Day +5 -26.98% 2025-03-19 Best recovery within 5 -23.72% 2025-03-17 20.8% of the drop was recovered five sessions later. Month end -31.81% on 2025-03-31
Close before and after $5.38 to $3.54 split-adjusted Session open, high, low $4.90, $4.90, $3.02 Opening gap -8.84% Close inside the session range 0.28 of the range, where 1.00 is the high Session volume 418,467 shares, $1,482,838 Relative volume 14.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
36	HTCO	-33.80%	2025-03-11 against the close of 2025-03-10 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	High-Trend International Group Announces the Completion of a $4,452,999 Private Placement of Ordinary Shares to Its Co-Founder, Mr. Dong Zhang At a Price of $2.62 Per Share with a Three-year Lock-up 03/11/2025 09:00 ET premarket	Day +1 -20.19% 2025-03-12 Day +5 -21.13% 2025-03-18 Best recovery within 5 -20.19% 2025-03-12 37.5% of the drop was recovered five sessions later. Month end -46.95% on 2025-03-31
Close before and after $53.25 to $35.25 split-adjusted Session open, high, low $49.50, $53.25, $32.63 Opening gap -7.04% Close inside the session range 0.13 of the range, where 1.00 is the high Session volume 7,538 shares, $265,715 Relative volume 1.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
37	ECX	-33.63%	2025-03-28 against the close of 2025-03-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	ECARX Holdings Inc. Announces Proposed Offering of 25,000,000 Class A Ordinary Shares 03/27/2025 16:50 ET after hours ECARX Holdings Inc. Announces Pricing of Offering of 25,000,000 Class A Ordinary Shares 03/28/2025	Day +1 -44.25% 2025-03-31 Day +5 -53.98% 2025-04-04 Best recovery within 5 -44.25% 2025-03-31 Five sessions later the drop was 60.5% bigger, at -53.98%. Month end -44.25% on 2025-03-31 This month ended before the fifth session after the move.
Close before and after $2.26 to $1.50 split-adjusted Session open, high, low $1.74, $1.75, $1.26 Opening gap -23.01% Close inside the session range 0.49 of the range, where 1.00 is the high Session volume 37,332,216 shares, $55,998,324 Relative volume 9.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
38	SAIH	-33.40%	2025-03-27 against the close of 2025-03-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Crypto & Treasury	SAIHEAT Announces Joining 1CP Program to Optimize Energy Costs for Bitcoin Mining 03/27/2025 09:29 ET premarket	Day +1 -54.94% 2025-03-28 Day +5 -54.48% 2025-04-03 Best recovery within 5 -47.03% 2025-04-02 Five sessions later the drop was 63.1% bigger, at -54.48%. Month end -49.82% on 2025-03-31 This month ended before the fifth session after the move.
Close before and after $8.59 to $5.72 split-adjusted Session open, high, low $7.86, $8.30, $5.27 Opening gap -8.53% Close inside the session range 0.15 of the range, where 1.00 is the high Session volume 53,499 shares, $306,014 Relative volume 11.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
39	SLE	-32.83%	2025-03-28 against the close of 2025-03-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Super League Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Update on Strategic Discussions to Accelerate Path to Profitability and Diversify Revenues 03/28/2025 07:30 ET premarket	Day +1 -40.66% 2025-03-31 Day +5 -48.08% 2025-04-04 Best recovery within 5 -38.23% 2025-04-01 Five sessions later the drop was 46.5% bigger, at -48.08%. Month end -40.66% on 2025-03-31 This month ended before the fifth session after the move.
Close before and after $190.08 to $127.68 split-adjusted Session open, high, low $177.60, $187.20, $125.04 Opening gap -6.57% Close inside the session range 0.04 of the range, where 1.00 is the high Session volume 1,132 shares, $144,534 Relative volume 3.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
40	ASBP under $25M today More than one ranked move this month 2+ ranked moves	-32.67%	2025-03-03 against the close of 2025-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Aspire Biopharma Holdings, Inc., to Launch the Next Generation of Pre-Workout Performance Supplement 03/03/2025 07:30 ET premarket	Day +1 -44.93% 2025-03-04 Day +5 -48.53% 2025-03-10 Best recovery within 5 -42.67% 2025-03-06 Five sessions later the drop was 48.5% bigger, at -48.53%. Month end -61.16% on 2025-03-31
Close before and after $1,800.00 to $1,212.00 split-adjusted Session open, high, low $2,004.00, $2,089.80, $1,140.00 Opening gap +11.33% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 495 shares, $599,940 Baseline gap 3 calendar days from the pre-news close to the measured session
41	CCLD	-32.37%	2025-03-06 against the close of 2025-03-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	CareCloud Announces Conversion of Series A Preferred Stock 03/06/2025 09:00 ET premarket	Day +1 -46.79% 2025-03-07 Day +5 -48.72% 2025-03-13 Best recovery within 5 -46.15% 2025-03-10 Five sessions later the drop was 50.5% bigger, at -48.72%. Month end -55.45% on 2025-03-31
Close before and after $3.12 to $2.11 split-adjusted Session open, high, low $2.89, $2.89, $1.95 Opening gap -7.37% Close inside the session range 0.17 of the range, where 1.00 is the high Session volume 1,229,357 shares, $2,593,943 Relative volume 13.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
42	SAVA	-32.14%	2025-03-25 against the close of 2025-03-24 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data 03/25/2025 08:05 ET premarket	Day +1 -37.50% 2025-03-26 Day +5 -50.71% 2025-04-01 Best recovery within 5 -37.50% 2025-03-26 Five sessions later the drop was 57.8% bigger, at -50.71%. Month end -46.43% on 2025-03-31 This month ended before the fifth session after the move.
Close before and after $2.80 to $1.90 as traded Session open, high, low $2.18, $2.33, $1.80 Opening gap -22.14% Close inside the session range 0.19 of the range, where 1.00 is the high Session volume 16,259,718 shares, $30,893,464 Relative volume 10.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
43	CRMD	-31.85%	2025-03-25 against the close of 2025-03-24 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update 03/25/2025 07:30 ET premarket	Day +1 -33.52% 2025-03-26 Day +5 -43.64% 2025-04-01 Best recovery within 5 -33.52% 2025-03-26 Five sessions later the drop was 37.0% bigger, at -43.64%. Month end -42.80% on 2025-03-31 This month ended before the fifth session after the move.
Close before and after $10.77 to $7.34 split-adjusted Session open, high, low $8.69, $9.25, $6.92 Opening gap -19.31% Close inside the session range 0.18 of the range, where 1.00 is the high Session volume 18,784,049 shares, $137,874,920 Relative volume 27.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
44	NPWR	-31.46%	2025-03-10 against the close of 2025-03-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Net Power Reports Fourth Quarter 2024 Results and Provides Business Update 03/10/2025 07:30 ET premarket	Day +1 -53.54% 2025-03-11 Day +5 -53.39% 2025-03-17 Best recovery within 5 -53.10% 2025-03-14 Five sessions later the drop was 69.7% bigger, at -53.39%. Month end -62.05% on 2025-03-31
Close before and after $6.93 to $4.75 split-adjusted Session open, high, low $5.25, $5.33, $2.28 Opening gap -24.24% Close inside the session range 0.81 of the range, where 1.00 is the high Session volume 15,176,992 shares, $72,090,712 Relative volume 34.2x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
45	ABVE under $25M today	-31.10%	2025-03-03 against the close of 2025-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Above Food Ingredients Inc. Provides Update on Subsidiary Purely Canada Foods Corp. 03/02/2025 17:12 ET after hours	Day +1 -24.35% 2025-03-04 Day +5 -21.20% 2025-03-10 Best recovery within 5 -17.46% 2025-03-05 31.8% of the drop was recovered five sessions later. Month end +30.73% on 2025-03-31
Close before and after $0.4543 to $0.3130 as traded Session open, high, low $0.4900, $0.4900, $0.3000 Opening gap +7.86% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 528,632 shares, $165,462 Relative volume 1.9x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
46	TRAW under $25M today	-30.82%	2025-03-03 against the close of 2025-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Traws Pharma Reports Positive Results from An Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil 03/03/2025 07:00 ET premarket	Day +1 -27.79% 2025-03-04 Day +5 -16.92% 2025-03-10 Best recovery within 5 -14.50% 2025-03-07 45.1% of the drop was recovered five sessions later. Month end -30.51% on 2025-03-31
Close before and after $3.31 to $2.29 split-adjusted Session open, high, low $3.17, $3.25, $2.24 Opening gap -4.23% Close inside the session range 0.05 of the range, where 1.00 is the high Session volume 1,487,165 shares, $3,405,608 Relative volume 38.2x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
47	CURR release reads positive	-30.74%	2025-03-18 against the close of 2025-03-17 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement Release reads positive, stock fell 30.74%	CURRENC to Develop 500MW Hyperscale AI Data Center in Malaysia 03/18/2025 08:00 ET premarket CURRENC Group and ARC Group Jointly Launch $100 Million AI-Focused Infrastructure & Investment Fund 03/18/2025	Day +1 -29.57% 2025-03-19 Day +5 -34.24% 2025-03-25 Best recovery within 5 -29.57% 2025-03-19 Five sessions later the drop was 11.4% bigger, at -34.24%. Month end -41.25% on 2025-03-31
Close before and after $2.57 to $1.78 split-adjusted Session open, high, low $2.65, $2.73, $1.72 Opening gap +3.11% Close inside the session range 0.06 of the range, where 1.00 is the high Session volume 2,303,595 shares, $4,100,399 Relative volume 7.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
48	HUMA	-30.43%	2025-03-26 against the close of 2025-03-25 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Humacyte, Inc. Announces Proposed Public Offering of Common Stock 03/25/2025 16:01 ET after hours Humacyte, Inc. Announces Pricing of Public Offering of Common Stock 03/25/2025 Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 28, 2025 03/26/2025	Day +1 -30.09% 2025-03-27 Day +5 -49.22% 2025-04-02 Best recovery within 5 -30.09% 2025-03-27 Five sessions later the drop was 61.7% bigger, at -49.22%. Month end -40.70% on 2025-03-31 This month ended before the fifth session after the move.
Close before and after $2.88 to $2.00 split-adjusted Session open, high, low $2.02, $2.18, $1.96 Opening gap -29.74% Close inside the session range 0.19 of the range, where 1.00 is the high Session volume 26,042,347 shares, $52,084,694 Relative volume 12.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
49	QRHC release reads positive	-30.39%	2025-03-13 against the close of 2025-03-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change Release reads positive, stock fell 30.39%	Quest Resource Holding Corporation Announces Appointment of Perry Moss as CEO 03/12/2025 16:00 ET after hours Quest Resource Holding Corporation Reports Fourth Quarter and Fiscal Year 2024 Financial Results 03/12/2025	Day +1 -22.86% 2025-03-14 Day +5 -23.64% 2025-03-20 Best recovery within 5 -20.78% 2025-03-19 22.2% of the drop was recovered five sessions later. Month end -32.47% on 2025-03-31
Close before and after $3.85 to $2.68 split-adjusted Session open, high, low $3.22, $3.25, $2.61 Opening gap -16.36% Close inside the session range 0.11 of the range, where 1.00 is the high Session volume 713,055 shares, $1,910,987 Relative volume 10.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
50	GYRE	-30.21%	2025-03-18 against the close of 2025-03-17 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Gyre Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update 03/17/2025 16:15 ET after hours	Day +1 -16.29% 2025-03-19 Day +5 -22.72% 2025-03-25 Best recovery within 5 -16.29% 2025-03-19 24.8% of the drop was recovered five sessions later. Month end -37.13% on 2025-03-31
Close before and after $12.28 to $8.57 split-adjusted Session open, high, low $11.50, $11.50, $8.49 Opening gap -6.35% Close inside the session range 0.03 of the range, where 1.00 is the high Session volume 747,521 shares, $6,406,255 Relative volume 9.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
51	ACXP under $25M today release reads positive	-29.86%	2025-03-07 against the close of 2025-03-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Release reads positive, stock fell 29.86%	Acurx Pharmaceuticals, Inc. Announces $1.1 Million Registered Direct Offering 03/07/2025 08:00 ET premarket	Day +1 -30.97% 2025-03-10 Day +5 -29.29% 2025-03-14 Best recovery within 5 -28.68% 2025-03-12 1.9% of the drop was recovered five sessions later. Month end -40.18% on 2025-03-31
Close before and after $13.04 to $9.15 split-adjusted Session open, high, low $9.21, $10.00, $9.00 Opening gap -29.37% Close inside the session range 0.15 of the range, where 1.00 is the high Session volume 59,024 shares, $539,834 Relative volume 8.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
52	NFGC	-29.56%	2025-03-25 against the close of 2025-03-24 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	New Found Gold Corp. Announces Initial Mineral Resource Estimate 03/24/2025 18:45 ET after hours	Day +1 -34.59% 2025-03-26 Day +5 -30.82% 2025-04-01 Best recovery within 5 -24.53% 2025-03-31 Five sessions later the drop was 4.3% bigger, at -30.82%. Month end -24.53% on 2025-03-31 This month ended before the fifth session after the move.
Close before and after $1.59 to $1.12 split-adjusted Session open, high, low $1.19, $1.28, $1.08 Opening gap -25.16% Close inside the session range 0.20 of the range, where 1.00 is the high Session volume 7,030,663 shares, $7,874,343 Relative volume 10.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
53	MEI	-28.92%	2025-03-06 against the close of 2025-03-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Methode Electronics, Inc. Reports Fiscal 2025 Third Quarter Financial Results 03/05/2025 16:05 ET after hours	Day +1 -33.30% 2025-03-07 Day +5 -37.47% 2025-03-13 Best recovery within 5 -33.30% 2025-03-07 Five sessions later the drop was 29.6% bigger, at -37.47%. Month end -35.03% on 2025-03-31
Close before and after $9.82 to $6.98 split-adjusted Session open, high, low $7.37, $8.16, $6.80 Opening gap -24.95% Close inside the session range 0.13 of the range, where 1.00 is the high Session volume 1,570,312 shares, $10,960,778 Relative volume 6.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
54	UBX under $25M today	-28.77%	2025-03-24 against the close of 2025-03-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema 03/24/2025 07:01 ET premarket UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) on March 24, 2025 03/23/2025	Day +1 -30.68% 2025-03-25 Day +5 -43.01% 2025-03-31 Best recovery within 5 -30.68% 2025-03-25 Five sessions later the drop was 49.5% bigger, at -43.01%. Month end -43.01% on 2025-03-31
Close before and after $1.83 to $1.30 as traded Session open, high, low $1.38, $1.39, $1.16 Opening gap -24.38% Close inside the session range 0.61 of the range, where 1.00 is the high Session volume 1,963,140 shares, $2,552,082 Relative volume 21.7x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
55	SUNE under $25M today Also on the opposite board this month on both boards	-28.73%	2025-03-10 against the close of 2025-03-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change	SUNation Energy Names James Brennan Chief Financial Officer 03/10/2025 08:45 ET premarket	Day +1 -14.68% 2025-03-11 Day +5 +13.95% 2025-03-17 Best recovery within 5 +31.74% 2025-03-14 It recovered the whole drop and closed 13.95% above the pre-news price. Month end -17.99% on 2025-03-31
Close before and after $79.70 to $56.80 split-adjusted Session open, high, low $65.06, $69.08, $52.08 Opening gap -18.37% Close inside the session range 0.28 of the range, where 1.00 is the high Session volume 79,734 shares, $4,528,891 Relative volume 164.7x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
56	HYPR Also on the opposite board this month on both boards	-28.73%	2025-03-18 against the close of 2025-03-17 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results 03/17/2025 16:05 ET after hours	Day +1 -33.55% 2025-03-19 Day +5 -35.57% 2025-03-25 Best recovery within 5 -32.62% 2025-03-20 Five sessions later the drop was 23.8% bigger, at -35.57%. Month end -44.04% on 2025-03-31
Close before and after $1.28 to $0.9122 split-adjusted Session open, high, low $0.9499, $0.9800, $0.8700 Opening gap -25.79% Close inside the session range 0.38 of the range, where 1.00 is the high Session volume 3,685,806 shares, $3,362,192 Relative volume 13.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
57	RAPP release reads positive	-28.71%	2025-03-03 against the close of 2025-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change Release reads positive, stock fell 28.71%	Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development 03/03/2025 07:00 ET premarket	Day +1 -0.40% 2025-03-04 Day +5 -17.55% 2025-03-10 Best recovery within 5 +4.39% 2025-03-05 38.9% of the drop was recovered five sessions later. Month end 0.00% on 2025-03-31
Close before and after $10.03 to $7.15 split-adjusted Session open, high, low $9.65, $9.88, $7.13 Opening gap -3.79% Close inside the session range 0.01 of the range, where 1.00 is the high Session volume 428,651 shares, $3,064,855 Relative volume 3.8x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
58	DSP release reads positive	-28.51%	2025-03-04 against the close of 2025-03-03 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition Release reads positive, stock fell 28.51%	Viant Technology Announces Acquisition of Lockr 03/03/2025 16:05 ET after hours Viant Technology Announces Fourth Quarter and Full Year 2024 Financial Results 03/03/2025	Day +1 -23.59% 2025-03-05 Day +5 -32.56% 2025-03-11 Best recovery within 5 -23.59% 2025-03-05 Five sessions later the drop was 14.2% bigger, at -32.56%. Month end -37.16% on 2025-03-31
Close before and after $19.75 to $14.12 split-adjusted Session open, high, low $13.59, $15.24, $13.07 Opening gap -31.19% Close inside the session range 0.48 of the range, where 1.00 is the high Session volume 1,700,536 shares, $24,011,568 Relative volume 4.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
59	JRVR	-28.37%	2025-03-04 against the close of 2025-03-03 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	James River Announces Fourth Quarter 2024 Results 03/03/2025 16:30 ET after hours	Day +1 -24.90% 2025-03-05 Day +5 -19.59% 2025-03-11 Best recovery within 5 -16.94% 2025-03-07 30.9% of the drop was recovered five sessions later. Month end -14.29% on 2025-03-31
Close before and after $4.90 to $3.51 split-adjusted Session open, high, low $4.69, $4.69, $3.00 Opening gap -4.29% Close inside the session range 0.30 of the range, where 1.00 is the high Session volume 4,480,803 shares, $15,727,619 Relative volume 30.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
60	KSCP	-28.29%	2025-03-28 against the close of 2025-03-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Knightscope Announces $1.7 Million Registered Direct Offering of Common Stock 03/28/2025 08:48 ET premarket	Day +1 -31.22% 2025-03-31 Day +5 -34.88% 2025-04-04 Best recovery within 5 -30.00% 2025-04-02 Five sessions later the drop was 23.3% bigger, at -34.88%. Month end -31.22% on 2025-03-31 This month ended before the fifth session after the move.
Close before and after $4.10 to $2.94 split-adjusted Session open, high, low $3.18, $3.24, $2.82 Opening gap -22.56% Close inside the session range 0.29 of the range, where 1.00 is the high Session volume 689,565 shares, $2,027,321 Relative volume 3.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
61	NABL	-28.22%	2025-03-03 against the close of 2025-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	N-able Announces Fourth Quarter and Full-Year 2024 Results 03/03/2025 07:00 ET premarket	Day +1 -28.02% 2025-03-04 Day +5 -31.01% 2025-03-10 Best recovery within 5 -25.62% 2025-03-06 Five sessions later the drop was 9.9% bigger, at -31.01%. Month end -29.31% on 2025-03-31
Close before and after $10.03 to $7.20 split-adjusted Session open, high, low $8.45, $8.48, $7.07 Opening gap -15.75% Close inside the session range 0.09 of the range, where 1.00 is the high Session volume 4,264,880 shares, $30,707,136 Relative volume 6.2x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
62	AKBA	-28.17%	2025-03-20 against the close of 2025-03-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Akebia Therapeutics Announces Proposed Public Offering of Common Stock 03/19/2025 16:01 ET after hours Akebia Therapeutics Announces Pricing of Public Offering of Common Stock 03/19/2025	Day +1 -25.00% 2025-03-21 Day +5 -32.04% 2025-03-27 Best recovery within 5 -25.00% 2025-03-21 Five sessions later the drop was 13.7% bigger, at -32.04%. Month end -32.39% on 2025-03-31
Close before and after $2.84 to $2.04 split-adjusted Session open, high, low $2.26, $2.35, $1.95 Opening gap -20.42% Close inside the session range 0.22 of the range, where 1.00 is the high Session volume 26,580,463 shares, $54,224,145 Relative volume 10.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
63	DWTX	-27.76%	2025-03-13 against the close of 2025-03-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Dogwood Therapeutics, Inc. Announces Pricing of $4.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules 03/13/2025 09:00 ET premarket	Day +1 -42.80% 2025-03-14 Day +5 -36.17% 2025-03-20 Best recovery within 5 -36.17% 2025-03-20 Five sessions later the drop was 30.3% bigger, at -36.17%. Month end -53.18% on 2025-03-31
Close before and after $10.70 to $7.73 split-adjusted Session open, high, low $7.49, $8.27, $7.00 Opening gap -30.00% Close inside the session range 0.58 of the range, where 1.00 is the high Session volume 1,107,410 shares, $8,560,279 Relative volume 16.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
64	SUUN	-27.64%	2025-03-21 against the close of 2025-03-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	SolarBank Corporation Announces up to US$19 Million Equity Financing 03/21/2025 08:00 ET premarket	Day +1 -31.69% 2025-03-24 Day +5 -44.94% 2025-03-28 Best recovery within 5 -31.69% 2025-03-24 Five sessions later the drop was 62.6% bigger, at -44.94%. Month end -45.39% on 2025-03-31
Close before and after $4.45 to $3.22 as traded Session open, high, low $4.20, $4.20, $3.11 Opening gap -5.62% Close inside the session range 0.10 of the range, where 1.00 is the high Session volume 655,042 shares, $2,109,235 Relative volume 3.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
65	SDST under $25M today	-27.54%	2025-03-28 against the close of 2025-03-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Stardust Power Announces Year End 2024 Financial Results 03/27/2025 17:00 ET after hours	Day +1 -30.96% 2025-03-31 Day +5 -25.97% 2025-04-04 Best recovery within 5 -21.49% 2025-04-02 5.7% of the drop was recovered five sessions later. Month end -30.96% on 2025-03-31 This month ended before the fifth session after the move.
Close before and after $6.83 to $4.95 split-adjusted Session open, high, low $6.16, $6.16, $4.10 Opening gap -9.85% Close inside the session range 0.41 of the range, where 1.00 is the high Session volume 99,775 shares, $493,886 Relative volume 3.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
66	BKKT	-27.28%	2025-03-18 against the close of 2025-03-17 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Bakkt Reschedules Release of Fourth Quarter and Full Year 2024 Earnings Results and Conference Call 03/17/2025 16:15 ET after hours	Day +1 -27.44% 2025-03-19 Day +5 -5.38% 2025-03-25 Best recovery within 5 +7.79% 2025-03-24 80.3% of the drop was recovered five sessions later. Month end -32.42% on 2025-03-31
Close before and after $12.83 to $9.33 split-adjusted Session open, high, low $8.58, $9.42, $7.96 Opening gap -33.13% Close inside the session range 0.94 of the range, where 1.00 is the high Session volume 1,977,050 shares, $18,445,877 Relative volume 7.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
67	KBSX release reads positive	-27.10%	2025-03-24 against the close of 2025-03-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement Release reads positive, stock fell 27.10%	FST Corp. Introduces KBS-branded Graphite Golf Shaft Designed to Achieve Greater Shot Distance and Accuracy 03/24/2025 08:00 ET premarket	Day +1 -7.74% 2025-03-25 Day +5 -33.39% 2025-03-31 Best recovery within 5 -7.74% 2025-03-25 Five sessions later the drop was 23.2% bigger, at -33.39%. Month end -33.39% on 2025-03-31
Close before and after $3.10 to $2.26 split-adjusted Session open, high, low $3.00, $3.01, $2.20 Opening gap -3.23% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 389,456 shares, $880,171 Relative volume 35.1x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
68	MDB	-26.94%	2025-03-06 against the close of 2025-03-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	MongoDB, Inc. Announces Fourth Quarter and Full Year Fiscal 2025 Financial Results 03/05/2025 16:05 ET after hours	Day +1 -28.96% 2025-03-07 Day +5 -29.92% 2025-03-13 Best recovery within 5 -25.75% 2025-03-12 Five sessions later the drop was 11.1% bigger, at -29.92%. Month end -33.59% on 2025-03-31
Close before and after $264.13 to $192.98 split-adjusted Session open, high, low $207.09, $212.01, $192.79 Opening gap -21.60% Close inside the session range 0.01 of the range, where 1.00 is the high Session volume 14,213,839 shares, $2,742,986,650 Relative volume 10.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
69	NEGG	-26.87%	2025-03-14 against the close of 2025-03-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Newegg Announces Upcoming Share Combination 03/14/2025 08:00 ET premarket	Day +1 -24.31% 2025-03-17 Day +5 -20.65% 2025-03-21 Best recovery within 5 -20.65% 2025-03-21 23.1% of the drop was recovered five sessions later. Month end -32.77% on 2025-03-31
Close before and after $7.66 to $5.60 split-adjusted Session open, high, low $5.00, $6.78, $4.83 Opening gap -34.73% Close inside the session range 0.40 of the range, where 1.00 is the high Session volume 218,739 shares, $1,225,376 Relative volume 8.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
70	RC	-26.84%	2025-03-03 against the close of 2025-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Buyback / Dividend	Ready Capital Corporation Reports Fourth Quarter 2024 Results and Declares First Quarter 2025 Dividends 03/03/2025 07:36 ET premarket	Day +1 -28.57% 2025-03-04 Day +5 -25.97% 2025-03-10 Best recovery within 5 -22.66% 2025-03-07 3.2% of the drop was recovered five sessions later. Month end -26.55% on 2025-03-31
Close before and after $6.93 to $5.07 split-adjusted Session open, high, low $5.52, $5.70, $4.78 Opening gap -20.35% Close inside the session range 0.32 of the range, where 1.00 is the high Session volume 22,960,789 shares, $116,411,200 Relative volume 14.1x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
71	AIRJ	-26.73%	2025-03-26 against the close of 2025-03-25 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	AirJoule Technologies Announces Fourth Quarter and Full Year 2024 Results and Groundbreaking Performance of AirJoule® System 03/25/2025 17:09 ET after hours	Day +1 -30.61% 2025-03-27 Day +5 -28.39% 2025-04-02 Best recovery within 5 -28.39% 2025-04-02 Five sessions later the drop was 6.2% bigger, at -28.39%. Month end -36.15% on 2025-03-31 This month ended before the fifth session after the move.
Close before and after $7.22 to $5.29 split-adjusted Session open, high, low $7.04, $7.22, $5.21 Opening gap -2.49% Close inside the session range 0.04 of the range, where 1.00 is the high Session volume 469,025 shares, $2,481,142 Relative volume 11.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
72	ECOR	-26.54%	2025-03-13 against the close of 2025-03-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	electroCore Announces Full Year 2024 Financial Results 03/12/2025 16:05 ET after hours	Day +1 -34.15% 2025-03-14 Day +5 -38.23% 2025-03-20 Best recovery within 5 -34.15% 2025-03-14 Five sessions later the drop was 44.0% bigger, at -38.23%. Month end -48.54% on 2025-03-31
Close before and after $13.00 to $9.55 split-adjusted Session open, high, low $11.73, $11.73, $9.30 Opening gap -9.77% Close inside the session range 0.10 of the range, where 1.00 is the high Session volume 817,175 shares, $7,804,021 Relative volume 5.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
73	BON under $25M today More than one ranked move this month 2+ ranked moves	-25.78%	2025-03-20 against the close of 2025-03-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	BON Announces Revolutionary Postbiotic Blood Sugar Solution Nears Patent Launch 03/20/2025 09:00 ET premarket	Day +1 -51.04% 2025-03-21 Day +5 -57.47% 2025-03-27 Best recovery within 5 -51.04% 2025-03-21 Five sessions later the drop was 122.9% bigger, at -57.47%. Month end -73.31% on 2025-03-31
Close before and after $8.76 to $6.50 split-adjusted Session open, high, low $8.30, $8.30, $6.03 Opening gap -5.22% Close inside the session range 0.21 of the range, where 1.00 is the high Session volume 1,469,320 shares, $9,550,580 Relative volume 281.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
74	SNAL	-25.31%	2025-03-27 against the close of 2025-03-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Snail, Inc. Reports Fourth Quarter & Full Year 2024 Financial Results 03/26/2025 16:01 ET after hours	Day +1 -35.80% 2025-03-28 Day +5 -51.84% 2025-04-03 Best recovery within 5 -35.80% 2025-03-28 Five sessions later the drop was 104.8% bigger, at -51.84%. Month end -45.78% on 2025-03-31 This month ended before the fifth session after the move.
Close before and after $8.10 to $6.05 split-adjusted Session open, high, low $7.90, $7.90, $5.40 Opening gap -2.47% Close inside the session range 0.26 of the range, where 1.00 is the high Session volume 34,932 shares, $211,339 Relative volume 4.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
75	ASNS under $25M today	-25.26%	2025-03-28 against the close of 2025-03-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	Actelis Receives Significant New Orders to Modernize U.S. Military Bases with Rapid Deployment, Cyber Hardened Networking 03/28/2025 08:00 ET premarket	Day +1 -21.08% 2025-03-31 Day +5 -35.77% 2025-04-04 Best recovery within 5 -21.08% 2025-03-31 Five sessions later the drop was 41.6% bigger, at -35.77%. Month end -21.08% on 2025-03-31 This month ended before the fifth session after the move.
Close before and after $9.50 to $7.10 split-adjusted Session open, high, low $8.30, $8.30, $6.90 Opening gap -12.63% Close inside the session range 0.14 of the range, where 1.00 is the high Session volume 111,074 shares, $788,625 Relative volume 10.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
76	CNFR under $25M today	-25.18%	2025-03-31 against the close of 2025-03-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Conifer Holdings Reports 2024 Fourth Quarter and Year End Financial Results 03/28/2025 16:01 ET after hours	Day +1 -28.30% 2025-04-01 Day +5 -14.33% 2025-04-07 Best recovery within 5 -14.33% 2025-04-07 43.1% of the drop was recovered five sessions later. Month end -25.18% on 2025-03-31 same session This month ended before the fifth session after the move.
Close before and after $0.6830 to $0.5110 as traded Session open, high, low $0.6352, $0.6352, $0.4455 Opening gap -7.00% Close inside the session range 0.35 of the range, where 1.00 is the high Session volume 145,739 shares, $74,473 Relative volume 38.9x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
77	AUID under $25M today	-25.15%	2025-03-31 against the close of 2025-03-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	authID Announces Pricing of Approximately $8,150,000 Million Registered Direct Offering 03/31/2025 08:30 ET premarket	Day +1 -26.08% 2025-04-01 Day +5 -5.56% 2025-04-07 Best recovery within 5 -5.56% 2025-04-07 77.9% of the drop was recovered five sessions later. Month end -25.15% on 2025-03-31 same session This month ended before the fifth session after the move.
Close before and after $6.48 to $4.85 split-adjusted Session open, high, low $4.90, $5.11, $4.46 Opening gap -24.38% Close inside the session range 0.60 of the range, where 1.00 is the high Session volume 919,427 shares, $4,459,221 Relative volume 9.6x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
78	BTMD	-25.12%	2025-03-13 against the close of 2025-03-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Biote Reports Fourth Quarter and Full Year 2024 Financial Results 03/12/2025 16:05 ET after hours	Day +1 -8.29% 2025-03-14 Day +5 +2.44% 2025-03-20 Best recovery within 5 +2.93% 2025-03-19 It recovered the whole drop and closed 2.44% above the pre-news price. Month end -18.78% on 2025-03-31
Close before and after $4.10 to $3.07 split-adjusted Session open, high, low $3.70, $3.71, $3.04 Opening gap -9.76% Close inside the session range 0.04 of the range, where 1.00 is the high Session volume 1,602,274 shares, $4,918,981 Relative volume 13.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
79	FTRE	-25.05%	2025-03-03 against the close of 2025-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Fortrea Reports Fourth Quarter and Full-Year 2024 Results; Issues Full-Year 2025 Guidance 03/03/2025 06:45 ET premarket	Day +1 -20.87% 2025-03-04 Day +5 -26.14% 2025-03-10 Best recovery within 5 -20.87% 2025-03-04 Five sessions later the drop was 4.4% bigger, at -26.14%. Month end -45.49% on 2025-03-31
Close before and after $13.85 to $10.38 split-adjusted Session open, high, low $9.61, $11.99, $9.55 Opening gap -30.61% Close inside the session range 0.34 of the range, where 1.00 is the high Session volume 8,743,472 shares, $90,757,239 Relative volume 8.1x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
80	AQB under $25M today	-24.50%	2025-03-27 against the close of 2025-03-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	AquaBounty Technologies Announces Full Year 2024 Financial Results 03/27/2025 08:01 ET premarket	Day +1 -31.36% 2025-03-28 Day +5 -35.06% 2025-04-03 Best recovery within 5 -31.36% 2025-03-28 Five sessions later the drop was 43.1% bigger, at -35.06%. Month end -32.46% on 2025-03-31 This month ended before the fifth session after the move.
Close before and after $1.02 to $0.7701 split-adjusted Session open, high, low $0.9600, $1.01, $0.6623 Opening gap -5.88% Close inside the session range 0.31 of the range, where 1.00 is the high Session volume 1,433,117 shares, $1,103,643 Relative volume 78.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
81	ASAN	-24.22%	2025-03-11 against the close of 2025-03-10 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings catalyst from a later release the same session	Asana Announces CEO Succession Plan 03/10/2025 16:05 ET after hours Asana Announces Fourth Quarter and Fiscal Year 2025 Results 03/10/2025	Day +1 -19.60% 2025-03-12 Day +5 -16.01% 2025-03-18 Best recovery within 5 -15.71% 2025-03-17 33.9% of the drop was recovered five sessions later. Month end -12.65% on 2025-03-31
Close before and after $16.68 to $12.64 split-adjusted Session open, high, low $12.13, $13.53, $11.58 Opening gap -27.28% Close inside the session range 0.54 of the range, where 1.00 is the high Session volume 19,028,315 shares, $240,517,902 Relative volume 7.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
82	BKSY	-24.17%	2025-03-06 against the close of 2025-03-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	BlackSky Reports Fourth Quarter and Full Year 2024 Results 03/06/2025 07:00 ET premarket	Day +1 -25.30% 2025-03-07 Day +5 -33.33% 2025-03-13 Best recovery within 5 -25.30% 2025-03-07 Five sessions later the drop was 37.9% bigger, at -33.33%. Month end -41.44% on 2025-03-31
Close before and after $13.20 to $10.01 split-adjusted Session open, high, low $10.05, $11.37, $9.78 Opening gap -23.86% Close inside the session range 0.14 of the range, where 1.00 is the high Session volume 3,873,464 shares, $38,773,375 Relative volume 2.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
83	KSS	-24.07%	2025-03-11 against the close of 2025-03-10 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Kohl's Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results 03/11/2025 07:00 ET premarket	Day +1 -28.55% 2025-03-12 Day +5 -30.87% 2025-03-18 Best recovery within 5 -28.55% 2025-03-12 Five sessions later the drop was 28.3% bigger, at -30.87%. Month end -32.12% on 2025-03-31
Close before and after $12.05 to $9.15 split-adjusted Session open, high, low $10.43, $10.56, $8.75 Opening gap -13.49% Close inside the session range 0.22 of the range, where 1.00 is the high Session volume 50,325,470 shares, $460,478,051 Relative volume 6.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
84	PSTV More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards	-23.68%	2025-03-28 against the close of 2025-03-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Plus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights 03/27/2025 16:05 ET after hours	Day +1 -37.49% 2025-03-31 Day +5 -48.09% 2025-04-04 Best recovery within 5 -32.89% 2025-04-01 Five sessions later the drop was 103.1% bigger, at -48.09%. Month end -37.49% on 2025-03-31 This month ended before the fifth session after the move.
Close before and after $38.00 to $29.00 split-adjusted Session open, high, low $32.50, $33.99, $28.25 Opening gap -14.47% Close inside the session range 0.13 of the range, where 1.00 is the high Session volume 136,211 shares, $3,950,119 Relative volume 0.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
85	ICG	-23.54%	2025-03-26 against the close of 2025-03-25 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Intchains Group Limited Announces Entry into Agreement for Registered Direct Offering of its ADSs and Warrants 03/26/2025 07:00 ET premarket	Day +1 -27.43% 2025-03-27 Day +5 -44.17% 2025-04-02 Best recovery within 5 -27.43% 2025-03-27 Five sessions later the drop was 87.6% bigger, at -44.17%. Month end -34.22% on 2025-03-31 This month ended before the fifth session after the move.
Close before and after $4.12 to $3.15 split-adjusted Session open, high, low $3.41, $3.59, $2.85 Opening gap -17.23% Close inside the session range 0.41 of the range, where 1.00 is the high Session volume 136,566 shares, $430,183 Relative volume 10.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
86	MDCX under $25M today	-23.24%	2025-03-11 against the close of 2025-03-10 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Medicus Pharma Ltd. Announces Closing of $4.2 Million Regulation A Offering 03/10/2025 16:05 ET after hours	Day +1 -3.24% 2025-03-12 Day +5 -9.41% 2025-03-18 Best recovery within 5 +1.18% 2025-03-13 59.5% of the drop was recovered five sessions later. Month end +9.41% on 2025-03-31
Close before and after $3.40 to $2.61 split-adjusted Session open, high, low $3.25, $3.30, $2.42 Opening gap -4.41% Close inside the session range 0.22 of the range, where 1.00 is the high Session volume 137,323 shares, $358,413 Relative volume 1.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
87	ELTK	-23.16%	2025-03-11 against the close of 2025-03-10 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Eltek Ltd. Reports Full Year and Fourth Quarter 2024 Financial Results 03/11/2025 08:30 ET premarket	Day +1 -21.50% 2025-03-12 Day +5 -19.58% 2025-03-18 Best recovery within 5 -19.58% 2025-03-18 15.5% of the drop was recovered five sessions later. Month end -23.61% on 2025-03-31
Close before and after $10.91 to $8.38 split-adjusted Session open, high, low $8.60, $8.95, $8.05 Opening gap -21.14% Close inside the session range 0.37 of the range, where 1.00 is the high Session volume 181,476 shares, $1,520,751 Relative volume 21.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
88	PLRZ under $25M today	-22.93%	2025-03-31 against the close of 2025-03-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Polyrizon Ltd. Announces $17.0 Million Private Placement 03/31/2025 09:32 ET intraday	Day +1 -23.85% 2025-04-01 Day +5 -18.65% 2025-04-07 Best recovery within 5 -18.13% 2025-04-02 18.7% of the drop was recovered five sessions later. Month end -22.93% on 2025-03-31 same session This month ended before the fifth session after the move.
Close before and after $718.20 to $553.50 split-adjusted Session open, high, low $735.00, $930.00, $420.90 Opening gap +2.34% Close inside the session range 0.26 of the range, where 1.00 is the high Session volume 1,152 shares, $637,632 Relative volume 18.6x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
89	ICU under $25M today	-22.73%	2025-03-28 against the close of 2025-03-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates 03/27/2025 16:05 ET after hours	Day +1 -24.55% 2025-03-31 Day +5 -36.82% 2025-04-04 Best recovery within 5 -24.55% 2025-03-31 Five sessions later the drop was 62.0% bigger, at -36.82%. Month end -24.55% on 2025-03-31 This month ended before the fifth session after the move.
Close before and after $22.00 to $17.00 split-adjusted Session open, high, low $18.00, $19.07, $15.61 Opening gap -18.18% Close inside the session range 0.40 of the range, where 1.00 is the high Session volume 64,507 shares, $1,096,619 Relative volume 3.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
90	WINT under $25M today Also on the opposite board this month on both boards	-22.68%	2025-03-04 against the close of 2025-03-03 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Windtree Announces Istaroxime Notice of Allowance from the U.S. Patent and Trademark Office for Acute Heart Failure 03/04/2025 08:00 ET premarket	Day +1 -36.08% 2025-03-05 Day +5 -31.27% 2025-03-11 Best recovery within 5 -29.90% 2025-03-06 Five sessions later the drop was 37.9% bigger, at -31.27%. Month end -56.70% on 2025-03-31
Close before and after $2.91 to $2.25 split-adjusted Session open, high, low $2.37, $2.65, $2.08 Opening gap -18.56% Close inside the session range 0.30 of the range, where 1.00 is the high Session volume 9,330,484 shares, $20,993,589 Relative volume 71.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
91	CISO under $25M today	-22.63%	2025-03-20 against the close of 2025-03-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	CISO Global’s AI-Powered Penetration Testing and Analysis Tool to make Real-time Assessments a Reality 03/20/2025 09:15 ET premarket	Day +1 -15.38% 2025-03-21 Day +5 -25.37% 2025-03-27 Best recovery within 5 -15.38% 2025-03-21 Five sessions later the drop was 12.1% bigger, at -25.37%. Month end -28.59% on 2025-03-31
Close before and after $0.6204 to $0.4800 split-adjusted Session open, high, low $0.6310, $0.6400, $0.4600 Opening gap +1.71% Close inside the session range 0.11 of the range, where 1.00 is the high Session volume 1,580,674 shares, $758,724 Relative volume 5.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
92	MODV under $25M today	-22.54%	2025-03-07 against the close of 2025-03-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change	Modivcare Reports Fourth Quarter and Full Year 2024 Financial Results; Announces Changes to the Board of Directors 03/06/2025 16:23 ET after hours	Day +1 -28.59% 2025-03-10 Day +5 -35.21% 2025-03-14 Best recovery within 5 -28.59% 2025-03-10 Five sessions later the drop was 56.2% bigger, at -35.21%. Month end -62.96% on 2025-03-31
Close before and after $3.55 to $2.75 as traded Session open, high, low $3.55, $4.47, $2.70 Opening gap 0.00% Close inside the session range 0.03 of the range, where 1.00 is the high Session volume 1,340,484 shares, $3,686,331 Relative volume 3.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
93	KLC	-22.17%	2025-03-21 against the close of 2025-03-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	KinderCare Reports Fourth Quarter 2024 Financial Results 03/20/2025 16:15 ET after hours	Day +1 -21.66% 2025-03-24 Day +5 -32.41% 2025-03-28 Best recovery within 5 -21.66% 2025-03-24 Five sessions later the drop was 46.2% bigger, at -32.41%. Month end -34.45% on 2025-03-31
Close before and after $17.68 to $13.76 split-adjusted Session open, high, low $14.80, $15.50, $13.53 Opening gap -16.29% Close inside the session range 0.12 of the range, where 1.00 is the high Session volume 3,618,130 shares, $49,785,469 Relative volume 9.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
94	LUNR Also on the opposite board this month on both boards	-22.11%	2025-03-07 against the close of 2025-03-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Intuitive Machines Lands and Operates Second Mission on the Moon 03/06/2025 18:37 ET after hours Intuitive Machines Executes Southernmost Lunar Landing and Operates Payloads 03/07/2025	Day +1 -39.79% 2025-03-10 Day +5 -35.08% 2025-03-14 Best recovery within 5 -34.10% 2025-03-12 Five sessions later the drop was 58.7% bigger, at -35.08%. Month end -33.84% on 2025-03-31
Close before and after $11.26 to $8.77 split-adjusted Session open, high, low $7.26, $9.55, $7.05 Opening gap -35.52% Close inside the session range 0.69 of the range, where 1.00 is the high Session volume 52,216,421 shares, $457,938,012 Relative volume 4.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
95	GME	-22.11%	2025-03-27 against the close of 2025-03-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	GameStop Announces Proposed Private Offering of $1.3 Billion of Convertible Senior Notes 03/26/2025 16:05 ET after hours	Day +1 -23.38% 2025-03-28 Day +5 -25.60% 2025-04-03 Best recovery within 5 -19.99% 2025-04-02 Five sessions later the drop was 15.8% bigger, at -25.60%. Month end -21.30% on 2025-03-31 This month ended before the fifth session after the move.
Close before and after $28.36 to $22.09 split-adjusted Session open, high, low $25.87, $26.28, $21.16 Opening gap -8.80% Close inside the session range 0.18 of the range, where 1.00 is the high Session volume 96,733,093 shares, $2,136,834,024 Relative volume 24.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
96	WKHS	-22.00%	2025-03-17 against the close of 2025-03-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Workhorse Group Sets Fourth Quarter and Full Year 2024 Earnings Call for Monday, March 31, 2025 at 10:00 a.m. ET 03/17/2025 08:30 ET premarket	Day +1 -18.54% 2025-03-18 Day +5 -15.85% 2025-03-24 Best recovery within 5 -15.47% 2025-03-20 28.0% of the drop was recovered five sessions later. Month end -29.30% on 2025-03-31
Close before and after $31.23 to $24.36 split-adjusted Session open, high, low $31.80, $34.82, $24.36 Opening gap +1.83% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 78,309 shares, $1,907,607 Relative volume 4.1x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
97	SNES under $25M today	-21.93%	2025-03-10 against the close of 2025-03-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	SenesTech Announces Warrant Exercise for $1.1 Million in Gross Proceeds 03/10/2025 08:00 ET premarket	Day +1 -20.93% 2025-03-11 Day +5 -25.58% 2025-03-17 Best recovery within 5 -20.27% 2025-03-13 Five sessions later the drop was 16.6% bigger, at -25.58%. Month end -39.87% on 2025-03-31
Close before and after $3.01 to $2.35 split-adjusted Session open, high, low $2.50, $2.60, $2.30 Opening gap -16.94% Close inside the session range 0.17 of the range, where 1.00 is the high Session volume 180,387 shares, $423,909 Relative volume 2.6x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
98	FGEN	-21.80%	2025-03-18 against the close of 2025-03-17 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	FibroGen Reports Fourth Quarter and Full Year 2024 Financial Results 03/17/2025 16:05 ET after hours	Day +1 -19.62% 2025-03-19 Day +5 -23.01% 2025-03-25 Best recovery within 5 -17.08% 2025-03-24 Five sessions later the drop was 5.6% bigger, at -23.01%. Month end -30.36% on 2025-03-31
Close before and after $11.13 to $8.70 as traded Session open, high, low $9.42, $9.87, $7.75 Opening gap -15.37% Close inside the session range 0.45 of the range, where 1.00 is the high Session volume 116,104 shares, $1,010,105 Relative volume 2.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
99	ASBP under $25M today More than one ranked move this month 2+ ranked moves	-21.62%	2025-03-13 against the close of 2025-03-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform 03/13/2025 08:30 ET premarket	Day +1 -16.22% 2025-03-14 Day +5 -7.00% 2025-03-20 Best recovery within 5 -7.00% 2025-03-20 67.6% of the drop was recovered five sessions later. Month end -21.27% on 2025-03-31
Close before and after $888.00 to $696.00 split-adjusted Session open, high, low $904.20, $904.20, $624.00 Opening gap +1.82% Close inside the session range 0.26 of the range, where 1.00 is the high Session volume 12,244 shares, $8,521,824 Baseline gap 1 calendar day from the pre-news close to the measured session
100	AISP	-21.58%	2025-03-03 against the close of 2025-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Airship AI Reports Full Year 2024 Financial Results 03/03/2025 08:31 ET premarket	Day +1 -22.88% 2025-03-04 Day +5 -22.17% 2025-03-10 Best recovery within 5 -15.09% 2025-03-05 Five sessions later the drop was 2.7% bigger, at -22.17%. Month end -8.96% on 2025-03-31
Close before and after $4.24 to $3.33 split-adjusted Session open, high, low $4.20, $4.28, $3.15 Opening gap -0.94% Close inside the session range 0.15 of the range, where 1.00 is the high Session volume 2,829,615 shares, $9,408,470 Relative volume 1.5x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 222 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Exclude the $5M to $25M band

9 candidate events for this board could not be anchored to a trading session and are not listed.

1 event was left out of this board because the ticker had not traded for more than 10 days before the measured session, so no comparable prior close exists.

Company names are not shown on months older than a year, because only the current holder of each ticker is known.

In March 2025, the median decliner was 11.1% deeper below its pre-news close five sessions later; the largest catalyst group was Earnings, 40 of the 100 events, at a median of -27.9%.

Close-to-close change on the measured trading session, against the previous close.

Which catalysts drove the board

Swipe the table sideways for the day +5 columns.

Catalyst	Events	Share of board	Median move close to close	Median at day +5	Still below the pre-news close at day +5
Earnings	40	40.0%	-27.9%	-31.5%	97.5% of 40
Other Announcement	23	23.0%	-32.4%	-45.2% of 20	100.0% of 20
Offering / Dilution	18	18.0%	-29.1%	-33.5%	94.4% of 18
Clinical Trial Results	8	8.0%	Fewer than 10 events in this group, so no figures are shown.
Leadership Change	4	4.0%	Fewer than 10 events in this group, so no figures are shown.

The day +5 figures are measured over the events in each group that have a five-session close, the count printed beside them, not over every event in the group.

5 other catalyst types, 7 events: FDA & Regulatory, Buyback / Dividend, M&A / Acquisition, Contract / Partnership, Crypto & Treasury.

How much of the drop held

Horizon	Still below the pre-news close close to close	Median change since the measured close as a share of the drop
Day +1	100.0% of 99	5.6% deeper below baseline, of 99
Day +5	96.9% of 97	11.1% deeper below baseline, of 97
Month end	95.7% of 92	24.3% deeper below baseline, of 92
Month end falls before day +5 for 24 of these 92 events, so this row is not a later horizon than the one above it. 92 of the 100 events have a month-end close later than the measured session; 4 have it on the measured session itself, and 4 have no month-end close.

Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.

Repeat runners

Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.

Moved twice or more inside March 2025

Two or more ranked moves this month, each on a different trading day.

Symbol	Measured sessions	Largest drop
BON	2Offering / Dilution, Other Announcement	-57.46%
PSTV	2Offering / Dilution, Earnings	-54.21%
BHIL	2Other Announcement	-41.19%
ASBP	2Other Announcement	-32.67%

Also fallen on news in earlier months

Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.

Symbol	Months	Largest drop
VIRX	2025-02, 2024-12	-49.83%
SVRE	2025-02, 2025-01	-30.61%
BZAI	2025-02, 2025-01	-32.29%
TNXP	2025-02, 2024-12	-37.00%
CADL	2025-02, 2024-12	-31.12%
GOEV	2025-01, 2024-12	-72.59%
PHIO	2025-01, 2024-12	-45.76%
LAES	2025-01, 2024-12	-41.54%
LICN	2025-01, 2024-12	-34.06%
LITM	2025-01, 2024-12	-63.14%
BDMD	2025-01, 2024-12	-38.95%
GXAI	2025-01, 2024-12	-27.02%

What the board was made of

Price before the move

Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.

When the announcement landed

Volume against normal

2 events have too little trading history for a relative volume, and are not in the tiers above.

Industry

34 other industries, 40 events

Industry not known: 15.0%

When the release and the price disagreed

10 events on this board carry the flag.

Flagged events sat 1.4 percentage points above the rest of the board five sessions later.

Median at day +5, flagged: -33.8%
Median at day +5, not flagged: -35.2%

Against February 2025

100 events in the comparable window.

February 2025 median -31.4%, selected from the 9,679 events in that month's eligible pool

March 2025 median -30.0%, 1.4 points shallower than February 2025. March 2025's median is taken over the 100 ranked rows, selected from the 8,656 events in that month's eligible pool.

How this ranking is measured

Close-to-close change on the measured trading session, against the previous close.

An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.

Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.

Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.

Market cap is not shown on months older than a year, because only today's figure exists.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

This archive starts at 2020-04, the first month with ranked moves.